A detailed history of Ascent Group, LLC transactions in Viatris Inc stock. As of the latest transaction made, Ascent Group, LLC holds 41,973 shares of VTRS stock, worth $445,333. This represents 0.04% of its overall portfolio holdings.

Number of Shares
41,973
Previous 42,534 1.32%
Holding current value
$445,333
Previous $460,000 8.91%
% of portfolio
0.04%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $6,322 - $7,590
-561 Reduced 1.32%
41,973 $501,000
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $894 - $1,106
102 Added 0.24%
42,534 $460,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $11,287 - $13,358
1,177 Added 2.85%
42,432 $418,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $189,465 - $216,141
21,005 Added 103.73%
41,255 $411,000
Q1 2023

May 10, 2023

BUY
$9.2 - $12.26 $26,569 - $35,406
2,888 Added 16.63%
20,250 $194,000
Q4 2022

Feb 16, 2023

BUY
$8.72 - $11.56 $151,396 - $200,704
17,362 New
17,362 $193,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Ascent Group, LLC Portfolio

Follow Ascent Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ascent Group, LLC with notifications on news.